ArticleResearch square2023

First-in-human clinical trial of personalized neoantigen vaccines as early intervention in untreated patients with lymphoplasmacytic lymphoma.

Larry Kwak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.